As a result of progress in biomedical technology, in many medical disciplines it is now possible to use implants to replace the function of irreversibly damaged organs and tissues and thus to improve the patient's quality of life. However more research is urgently needed, as implants frequently lose their function because of biofilm-associated infections or loss of biointegration. New interdisciplinary strategies have to be developed to improve the biocompatibility and long-term stability of implants, as well as to avoid implant infections and chronic destructive immune reactions.
The two parts of the current issue of BioNanoMaterials focus on the Biofabrication of implant materials and implant functionalisation. To improve implant stability and safety, new organic and inorganic biomaterials must be developed. In many ways, collagen and fibrin are ideal scaffold materials for tissue regeneration, even though the mechanical properties of pure collagen and fibrin are poor. Schneider-Barthold et al. [1] review methods to modify collagen and fibrin to give next-generation materials with enhanced stability. Additionally a new technique has been developed to generate highly stable fibrin tubes, which are a powerful tool for the generation of customised bioartificial vascular grafts [2] . Furthermore hydrogel-based microfluidics have been developed for vascular tissue engineering [3] . Recent advantages in nanotechnology have excited interest in the use of nanoparticles in medicine, Seleci et al. [4] present an overview of smart multifunctional nanoparticles in nanomedicine and Modrojewski et al. [5] describe the generation of aptamer-modified polymer nanoparticles for targeted drug delivery.
Implant-associated infections are still one of the most important challenges in modern medicine. These infections are caused by bacterial biofilms that colonise implant surfaces. Biofilm-associated infections result in inflammation, accompanied by destruction of surrounding tissue. A common attribute of biofilms is their persistent nature and their increased resilience and resistance to external influences, such as antibiotics, host defence and shear forces. Resilience is afforded by a number of factors, which include strong cell-surface and cell-cell physicochemical interactions and the production of extracellular polymers. These act as a bacterial scaffold and can reduce dispersion by antimicrobials. Innovative implant surfaces have been developed for various medical disciplines, in order to generate both long-term anti-biofilm activity and good biointegration. Approaches include physical functionalisation of the surface by ultra-short pulse laser ablation [6] , as well as chemical functionalisation. Fullriede et al. [7] present the proof-of-principle of a pH-sensitive stimulus-response system for controlled drug release, for the local treatment of biofilm-associated infections. New experimental methods and new optical imaging procedures have been developed for the investigation of bacterial biofilms on implant surfaces [8] and an overview is given of 2D-and 3D-wound healing assays [9] .
Once initial results have been obtained from biomaterial development, these must be translated into clinical practise and patient care. However, this is an immense challenge, as registration procedures for the use in man of a medical device are complex and consist of extensive laboratory studies and graduated clinical testing. Translating the knowledge from biomedical developments into clinical applications has been compared to crossing a "valley of death". In the current issue of BioNanoMaterials Duda et al. [10] focus on clinical translation procedures within the national, institutional and socio-political context. Translation of medical innovations into clinical practise requires intelligent strategies in communication. The dialogue between science and the public has to be improved, in order to reduce anxiety about novel medical processes (public understanding of science) by presenting scientific and medical information in a comprehensible manner [11] . In general, the current issue of BioNanoMaterials demonstrates the interdisciplinary nature of the Biofabrication and functionalisation of biomaterials and the challenges of their translation to clinical use. These developments can make a major contribution to future work on implants and implant safety in a variety of medical disciplines. We hope that you will enjoy reading about the topics chosen for this issue and that this will help you to develop this crucial area of work!
